5-Azacytidine treatment for relapsed or refractory acute myeloid leukemia after intensive chemotherapy-Reference-Cited by-同舟云学术

5-Azacytidine treatment for relapsed or refractory acute myeloid leukemia after intensive chemotherapy

Published:2013-05-30 Issue:7 Volume:88 Page:601-605
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am. J. Hematol.

Author:

Ivanoff Sarah¹,Gruson Berengere¹,Chantepie Sylvain P.²,Lemasle Emilie³,Merlusca Lavinia¹,Harrivel Veronique⁴,Charbonnier Amandine¹,Votte Patrick⁵,Royer Bruno¹,Marolleau Jean-Pierre¹⁶

Affiliation:

1. Service d'Hématologie Clinique, CHU Amiens; France

2. Service d'Hématologie Clinique, CHU Caen; France

3. Service d'Hématologie Clinique, Centre Henri Becquerel; Rouen France

4. Laboratoire d'Hématologie, CHU Amiens; France

5. Pharmacie hospitalière, CHU Amiens; France

6. EA4666; Université Picardie Jules Verne; Amiens France

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ajh.23464/fullpdf

Reference23 articles.

1. The treatment of acute myeloid leukemia in first relapse: A comprehensive review of the literature;Leopold;Leuk Lymphoma,2002

2. Duration of second complete remission compared with first complete remission in patients with acute myeloid leukemia;Lee;Eastern Cooperative Oncology Group. Leukemia,2000

3. Prognostic index for adult patients with acute myeloid leukemia in first relapse;Breems;J Clin Oncol,2005

4. A new Leukemia Prognostic Scoring System for refractory/relapsed adult acute myelogeneous leukaemia patients: A GOELAMS study;Chevallier;Leukemia,2011

5. HLA-identical sibling bone marrow transplants vs;Gale;chemotherapy for acute myelogenous leukemia in first remission. Leukemia,1996

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treating acute myelogenous leukemia in patients aged 70 and above: Recommendations from the International Society of Geriatric Oncology (SIOG);Journal of Geriatric Oncology;2023-09

2. A review of treatment options employed in relapsed/refractory AML;Hematology;2023-04-10

3. Non-intensive acute myeloid leukemia therapies for older patients;Expert Review of Hematology;2023-03-02

4. Clinical Utility of Azacitidine in the Management of Acute Myeloid Leukemia: Update on Patient Selection and Reported Outcomes;Cancer Management and Research;2022-12

5. Myeloablative conditioning with thiotepa-busulfan-fludarabine does not improve the outcome of patients transplanted with active leukemia: final results of the GITMO prospective trial GANDALF-01;Bone Marrow Transplantation;2022-04-12